As our data show that DUSP4 depletion leads to cell death through MITF suppression, we evaluated the sensitivity of BRAF/NRAS–mutant melanoma cells expressing either high or low levels of MITF to DUSP4 knockdown. The gene discussed is NRAS; the disease is melanoma.